Photochemical & Photobiological Sciences
Paper
Kinetics of acid-induced spectral changes in the GFPmut2 22 S. Abbruzzetti, E. Crema, L. Masino, A. Vecli, C. Viappiani,
chromophore, J. Am. Chem. Soc., 2005, 127, 626–635.
C. Tallant, A. Marrero and F. X. Gomis-Rüth, Matrix metal-
loproteinases: Fold and function of their catalytic domains,
Biochim. Biophys. Acta, 2010, 1803, 20–28.
G. Murphy and H. Nagase, Progress in matrix metallopro-
teinase research, Mol. Aspects Med., 2008, 29, 290–308.
R. Visse and H. Nagase, Matrix metalloproteinases and
tissue inhibitors of metalloproteinases: structure, function,
and biochemistry, Circ. Res., 2003, 92, 827–839.
J. R. Small, L. J. Libertini and E. W. Small, Fast events in
protein folding: structural volume changes accompanying
the early events in the N → I transition of apomyoglobin
induced by ultrafast pH jump, Biophys. J., 2000, 78, 405–
415.
7
8
9
23 I. Schechter and A. Berger, On the size of the active site in
proteases. I. Papain, Biochem. Biophys. Res. Commun., 1967,
27, 157–162.
24 C. M. Overall and O. Kleifeld, Towards third generation
matrix metalloproteinase inhibitors for cancer therapy,
Br. J. Cancer, 2006, 94, 941–946.
1
0 M. Grossman, B. Born, M. Heyden, D. Tworowski,
G. B. Fields, I. Sagi and M. Havenith, Correlated struc-
tural kinetics and retarded solvent dynamics at the 25 H. Matter and M. Schudok, Recent advances in the design
metalloprotease active site, Nat. Struct. Mol. Biol., 2011,
8, 1102–1108.
of matrix metalloprotease inhibitors, Curr. Opin. Drug Dis-
covery Dev., 2004, 7, 513–535.
1
1
1
1
1 H. Nagase and G. B. Fields, Human matrix metalloprotei- 26 J. M. Chen, F. C. Nelson, J. I. Levin, D. Mobilio, F. J. Moy,
nase specificity studies using collagen sequence-based syn-
thetic peptides, Biopolymers, 1996, 40, 399–416.
R. Nilakantan, A. Zask and R. Powers, Structure-Based
Design of a Novel, Potent, and Selective Inhibitor for
MMP-13 Utilizing NMR Spectroscopy and Computer-Aided
Molecular Design, J. Am. Chem. Soc., 2000, 122, 9648–9654.
27 S. P. Gupta and V. M. Patil, Specificity of Binding with Matrix
Metalloproteinases, Matrix Metalloproteinase Inhibitors,
Springer, 2012.
2 M. Heyden and M. Havenith, Combining THz spectroscopy
and MD simulations to study protein-hydration coupling,
Methods, 2010, 52, 74–83.
3 S. J. Kim, B. Born, M. Havenith and M. Gruebele, Real-time
detection of protein–water dynamics upon protein folding
by terahertz absorption spectroscopy, Angew. Chem., Int. 28 C. Fernandez-Catalan, W. Bode, R. Huber, D. Turk,
Ed., 2008, 47, 6486–6489.
J. J. Calvete, A. Lichte, H. Tschesche and K. Maskos, Crystal
structure of the complex formed by the membrane type
1-matrix metalloproteinase with the tissue inhibitor of
metalloproteinases-2, the soluble progelatinase A receptor,
EMBO J., 1998, 18, 5238–5248.
1
4 A. Jabaiah and P. S. Daugherty, Directed Evolution of Pro-
tease Beacons that Enable Sensitive Detection of Endogen-
ous MT1-MMP Activity in Tumor Cell Lines, Chem. Biol.,
2
011, 18, 392–401.
1
1
1
5 H. Nagase, R. Visse and G. Murphy, Structure and function 29 I. Bertini, I. Calderone, M. Fragai, C. Luchinat, M. Maletta
of matrix metalloproteinases and TIMPs, Cardiovasc. Res.,
006, 69, 562–573.
6 V. Pelmenschikov and P. E. M. Siegbahn, Catalytic mechan-
and K. J. Yeo, Snapshots of the Reaction Mechanism of
Matrix Metalloproteinases, Angew. Chem., Int. Ed., 2006, 45,
7952–7955.
2
ism of matrix metalloproteinases: Two-layered ONIOM 30 J. Berman, M. Green, E. Sugg, R. Anderegg,
study, Inorg. Chem., 2002, 41, 5659–5666.
D. S. Millington, D. L. Norwood, J. Mcgeehan and
J. Wiseman, Rapid Optimization of Enzyme Substrates
Using Defined Substrate Mixtures, J. Biol. Chem., 1992, 267,
1434–1437.
7 H. Ogata, E. Decaneto, M. Grossman, M. Havenith, I. Sagi,
W. Lubitz and M. Knipp, Crystalization and preliminary
X-ray crystallographic analysis of the catalytic domain of
membrane type 1 matrix metalloproteinase, Acta Crystal- 31 Y. Tatsu, Y. Shigeri, A. Ishida, K. Isamu, H. Fujisawa and
logr., Sect. F: Struct. Biol. Cryst. Commun., 2014, 70, 232–
35.
8 G. B. Fields, Using Fluorogenic Peptide Substrates to Assay
N. Yumoto, Synthesis of caged peptides using caged lysine:
Application to the synthesis of caged AIP, a highly specific
inhibitor of calmodulin-dependent protein kinase II,
Bioorg. Med. Chem. Lett., 1999, 9, 1093–1096.
2
1
1
2
Matrix Metalloproteinases, Methods Mol. Biol., 2000, 151,
4
95–518.
32 Y. Shigeri, Y. Tatsu and N. Yumoto, Synthesis and appli-
cation of caged peptides and proteins, Pharmacol. Ther.,
2001, 91, 85–92.
33 S. Walbert, W. Pfleiderer and U. E. Steiner, Photolabile Pro-
tecting Groups for Nucleosides: Mechanistic Studies of the
2-(2-Nitrophenyl)ethyl Group, Helv. Chim. Acta, 2001, 84,
1601–1611.
9 R. C. Wahl, The calculation of initial velocity from product
progress curves when [S]<<Km, Anal. Biochem., 1994, 383–
3
84.
0 U. Neumann, H. Kubota, K. Frei, V. Ganu and D. Leppert,
Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-
NH , a fluorogenic substrate with increased specificity con-
2
stants for collagenases and tumor necrosis factor convert- 34 R. A. McClelland and S. Steenken, Pronounced solvent
ing enzyme, Anal. Biochem., 2004, 328, 166–173.
1 S. Abbruzzetti, S. Sottini, C. Viappiani and J. E. T. Corrie,
Kinetics of proton release after flash photolysis of 1-(2-
effect on the absorption spectra of the photochemically
produced 2,4-dinitrobenzyl carbanion, Can. J. Chem., 1987,
65, 353–356.
2
nitrophenyl)ethyl sulfate (caged sulfate) in aqueous solu- 35 S. J. Atherton and B. B. Craig, Laser photolysis of 2,6-dinitro-
tion, J. Am. Chem. Soc., 2005, 127, 9865–9874. toluene in solution, Chem. Phys. Lett., 1986, 127, 7–12.
This journal is © The Royal Society of Chemistry and Owner Societies 2014
Photochem. Photobiol. Sci.